Sponsored by BaseLaunch
7 Mar 2023Basel: It Takes an Ecosystem to Build a Startup
Europe has a number of bubbling biotech hubs that offer access to expertise, financial support, and networking opportunities for young…
About
Science journalist at Labiotech.eu. Born half Kiwi, half German. I have a BSc in Biology and an MSc in Science Communication from different Universities. I love writing, painting and eating chocolate. Sometimes, I share.Articles by Larissa Warneck-Silvestrin
Reports by Medpace
28 Jul 2022A toolkit for emerging biotechs: practical advice for navigating challenges and advancing clinical development
By 2030, the global biotech industry is expected to reach a market value of $1,684B. At the forefront of the…
Sponsored by Collaborative Drug Discovery Inc.
15 Mar 2022How Managing Data Effectively Helps Fight Antimicrobial Resistance
Collaborative Drug Discovery The crisis of antibiotic resistance is making the discovery and development of new antibiotics crucial, and companies…
Infographics by WuXi AppTec
1 Mar 2022Infographic: Drugging the Undruggable: Leveraging the Right Screening Methods for Challenging Targets
Challenging targets, such as membrane proteins or protein-protein interactions were considered undruggable in the past. However, today a variety of…
ADVERTISEMENT
Best in Biotech 20 Dec 2021
The Billion-Euro European Biotech Companies in 2022
Here’s a list of the public European biotech companies that are worth more than a billion euros in 2022. European…
Best in Biotech 9 Jun 2021
Top 15 Swiss biotech startups making a difference in Europe
Switzerland has long been known as a booming biotech hotspot in Europe that boasts many high-profile companies. Here are the…
Interview 31 May 2021
What’s Ahead for European Biotech Startups After Covid?
With a tumultuous year behind us, 2021 is set out to spell change for many startups in the European biotech…
Interview 10 May 2021
The Rollercoaster of Repurposing an Arthritis Drug for Covid-19
The Covid-19 pandemic created an opportunity for many biotech companies to repurpose their existing programs into vaccines and treatments for…
Interview 5 Apr 2021
Base Editing: The Next Frontier in Genome Editing Technology
Jonathan Frampton, Corporate Development Partner at Horizon Discovery, a Perkin Elmer company, shares his insights into the promises of base…
Interview 15 Mar 2021
Developing a Vaccine that Protects Against Covid-19 Variants
Despite the promise of several approved Covid-19 vaccines and the widespread rollout of vaccination programs around the world, recent mutations…
ADVERTISEMENT
Interview 3 Mar 2021
The Promises of CRISPR Genome Editing in Biomedicine
Tony Ho, Head of Research and Development at CRISPR Therapeutics, offers his insights into the advantages of CRISPR gene editing…
Best in Biotech 25 Jan 2021
The 15 Best Biotech Companies in Belgium
Meet the most successful biotech companies in Belgium, a small country that makes a huge contribution to the biotech industry. …
Best in Biotech 11 Jan 2021
The 21 European Biotech Companies To Watch in 2021
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list of 21 European biotech companies…
Reports by CrownBio
1 Dec 2020Report: Are Tumor Organoids the Future of Cancer Drug Development?
Over the last decade, oncology drug development has been marred by the high attrition rates of new anticancer agents. These…
Reports 11 Nov 2020
Navigating the Immunotherapy Maze
Today, the global immunotherapy drugs market is valued at €139B ($163B) and is estimated to reach a staggering value of…
Interview 28 Oct 2020
Do Natural Killer Cells Hold the Key to Treating Blood Cancers?
Novel immunotherapies, like T cell therapy, may have shown recent successes but they also come with a number of setbacks,…
ADVERTISEMENT
Infographics by Merck
26 Oct 2020Ensuring Viral Vector Supply for Gene Therapies
While the success of gene therapies has boosted investments in the sector, it has also led to a number of…
Interview 5 Oct 2020
How is Germany Meeting Patient Demand for Medical Cannabis?
Since Germany legalized cannabis for medical use in 2017, we have frequently spoken to Peter Homberg, Partner and Head of…
Sponsored by Biovian
28 Sep 2020What Factors can Ease the Complexity of Viral Vector Production for Gene Therapies?
While the global gene therapy market grows steadily, companies continue to face bottlenecks in the production of gene therapy’s essential…
Reports 30 Jul 2020
Current and Emerging Therapeutic Approaches for Autoimmune Diseases
Over 4% of the world's population suffers from one or more of over 80 autoimmune diseases identified to date. A…